Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 4/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | THRA | P10827 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | PLK1 | P53350 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28312772 | 0.85 | CA1 (0.52) | CYP4F2CYP4A11DPP4ALDH1A1LMNA | |
| SCHEMBL21629612 | 0.85 | KDM4E (0.44) | CYP4F2CYP4A11DPP4THRBTHRA | |
| SCHEMBL25523231 | 0.82 | DPP4 (0.43) | CYP4F2CYP4A11DPP4MEN1HTT | |
| SCHEMBL16868406 | 0.79 | ALDH1A1 (0.55) | CYP4F2CYP4A11ALDH1A1LMNATDP1 | |
| SCHEMBL21753375 | 0.79 | SLC6A2 (0.46) | CYP4F2CYP4A11ALDH1A1CA1CA2 | |
| SCHEMBL9559796 | 0.79 | ALDH1A1 (0.55) | CYP4F2CYP4A11ALDH1A1LMNATDP1 | |
| SCHEMBL16868410 | 0.79 | ACACB (0.43) | CYP4F2CYP4A11ALDH1A1LMNATDP1 | |
| Hydrochloric Acid SCHEMBL9642916 | 0.79 | RARB (0.54) | THRBTHRAALDH1A1PLK1HSD17B10 | |
| SCHEMBL3007585 | 0.78 | CES2 (0.48) | CYP4F2CYP4A11ALDH1A1CYP3A4CYP2D6 | |
| SCHEMBL1707132 | 0.78 | CYP2D6 (0.36) | CYP4F2CYP4A11DPP4ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230204512-A1 | DETECTION PLATFORM AND METHOD FOR DETECTING ABUSED DRUGS | NATIONAL TAIWAN UNIVERSITY (TW) | 2023-06-29 | — | — | US | claimed |
| US-20260027148-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS | BEXSON BIOMEDICAL INC (US) | 2026-01-29 | — | — | US | disclosed |
| US-20260014191-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS | BEXSON BIOMEDICAL INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-20260014190-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS | BEXSON BIOMEDICAL INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12472201-B2 | Complexing agent salt formulations of pharmaceutical compounds | BEXSON BIOMEDICAL, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| US-20250345458-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL INC (US) | 2025-11-13 | — | — | US | disclosed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | disclosed |
| EP-4525916-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | Bexson Biomedical, Inc. (US) | 2025-03-26 | — | — | EP | disclosed |
| WO-2024084122-A1 | BODIPY-DERIVED COMPOUNDS FOR DRUG DETECTION | UNIVERSITAT DE VALÈNCIA (ES) | 2024-04-25 | — | — | WO | disclosed |
| WO-2023225113-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| EP-4247340-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS | Bexson Biomedical, Inc. (US) | 2023-09-27 | — | — | EP | disclosed |
| US-20230204512-A1 | DETECTION PLATFORM AND METHOD FOR DETECTING ABUSED DRUGS | NATIONAL TAIWAN UNIVERSITY (TW) | 2023-06-29 | — | — | US | disclosed |
| US-20230124101-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS | BEXSON BIOMEDICAL, INC. | 2023-04-20 | — | — | US | disclosed |
| US-11534454-B2 | Complexing agent salt formulations of pharmaceutical compounds | BEXSON BIOMEDICAL, INC. (US) | 2022-12-27 | — | — | US | disclosed |
| US-11360082-B2 | Detection kit and method for detecting abused drugs | NATIONAL TAIWAN UNIVERSITY (TW) | 2022-06-14 | — | — | US | disclosed |
| WO-2022109050-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS | BEXSON BIOMEDICAL, INC. (US) | 2022-05-27 | — | — | WO | disclosed |
| US-20220152088-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS | BEXSON BIOMEDICAL, INC. | 2022-05-19 | — | — | US | disclosed |
| US-20200225216-A1 | DETECTION KIT AND METHOD FOR DETECTING ABUSED DRUGS | NATIONAL TAIWAN UNIVERSITY (TW) | 2020-07-16 | — | — | US | disclosed |
| US-10041962-B1 | Sensing paper and method of sensing abused drugs | NATIONAL TAIWAN UNIVERSITY (TW) | 2018-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014191-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS | SLC6A4, SLC6A3, SIGMAR1 | CYP4F2 368/4885CYP4A11 304/4885DPP4 1163/4885 |
| US-20260027148-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS | SLC6A3, SIGMAR1, SLC6A4 | CYP4F2 308/4885CYP4A11 335/4885DPP4 1163/4885 |
| US-20220152088-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS | SLC10A1, SLC5A6, MC2R | CYP4F2 2372/4885CYP4A11 846/4885DPP4 521/4885 |
| US-11534454-B2 | Complexing agent salt formulations of pharmaceutical compounds | SLC10A1, SLC5A6, MC2R | CYP4F2 2372/4885CYP4A11 846/4885DPP4 521/4885 |
| US-20230124101-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS | SLC10A1, SLC5A6, MC2R | CYP4F2 2372/4885CYP4A11 846/4885DPP4 521/4885 |
| US-20250345458-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | MC2R, SLC26A3, SLC5A1 | CYP4F2 1937/4885CYP4A11 1098/4885DPP4 2150/4885 |
| US-12472201-B2 | Complexing agent salt formulations of pharmaceutical compounds | SLC10A1, SLC5A6, MC2R | CYP4F2 2372/4885CYP4A11 846/4885DPP4 521/4885 |
| US-20260014190-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS | SIGMAR1, OPRK1, SLC6A2 | CYP4F2 611/4885CYP4A11 744/4885DPP4 1999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.